In the peri-infarct-1 region, HK2 inhibitors attenuated the upregulation of pro-inflammatory gene expression observed in microglia at 12 h after stroke, and this correlated with a suppression of CD11b upregulation and the classical morphological changes observed at 48 h after stroke. Here, HK2 is linked to stroke disorder.